Heart failure (HF) is a worldwide global healthcare problem due to its high prevalence, incidence and associated mortality and morbidity [1,2]. Moreover, HF is associated with impaired health-related quality of life (QoL) and elevated healthcare costs [3–6]. A substantial burden of healthcare costs is largely due to the hospital admissions of these patients, therefore strategies for the prevention of these has been promoted over the last few years [7,8].
